Ambrosch F, Klima H, Wiedermann G
Dev Biol Stand. 1979;43:121-6.
BCG-vaccination in Austria is performed generally in newborn, but only partially in school children. A cost-benefit analysis was performed considering age-dependent immunizations, tuberculosis morbidity, protection rate and duration of protection, costs of vaccination, costs of tuberculosis therapy, frequency of complications due to vaccination and costs for treatment of these complications. This analysis shows an economic balance between costs and benefits with regard to immunication of newborn, i. e., costs of vaccination are approximately compensated by the saved costs of prevented diseases. In contrary vaccination of school children reveals a considerable economic gain. General revaccination of schoolchildren would make BCG-vaccination much more effective in an economic respect.
奥地利一般在新生儿中接种卡介苗，但在学龄儿童中仅部分接种。进行了一项成本效益分析，考虑了年龄依赖性免疫接种、结核病发病率、保护率和保护持续时间、疫苗接种成本、结核病治疗成本、疫苗接种引起的并发症发生率以及这些并发症的治疗成本。该分析表明，就新生儿免疫接种而言，成本与效益之间存在经济平衡，即疫苗接种成本大约可由预防疾病节省的成本所补偿。相反，学龄儿童接种疫苗则显示出可观的经济收益。对学龄儿童进行普遍再接种将使卡介苗接种在经济方面更具成效。
